Meeting Archives

NeuroRestorative Therapy Group

2023/2024 Schedule

October 4, 2023: Hao Chen (Kim lab, WashU Neurosurgery) “A reductionist perspective of the Hao-Fountain syndrome protein USP7 in the developing brain”
November 1, 2023: Venu Gurram (Urano lab, WashU Medicine) “Illuminating the Darkness: Developing MANF regenerative gene therapy for optic atrophy in Wolfram Syndrome”
January 3, 2024: David Curiel (WashU Radiation Oncology) “Targeted In Vivo Gene Delivery via Tropism Modified Adenoviral Vectors – A Thirty Year Quest for the Holy Grail”
February 7, 2024: Hong Chen (WashU Biomedical Engineering and Neurosurgery) “Breaking Barriers: Transforming the Diagnosis and Treatment of Brain Diseases Through Ultrasound”
March 6, 2024: Laura Campisi (WashU Pathology & Immunology) “T cell dysfunctions as biomarker and therapeutic target in ALS4”
April 3, 2024: Dylan Galloway (Miller lab, WashU Neurology) “Targeting microRNAs with antisense oligonucleotides to understand motor neuron disease”
May 1, 2024: Joseph Corbo (WashU Pathology & Immunology) “Mechanisms of photoreceptor protection upon targeting the Nrl-Nr2e3 pathway”

2022/2023 Schedule

October 5, 2022: Albert Kim (WashU Neurosurgery) “Modeling glioblastoma using human embryonic stem cells”
November 2, 2022: Hong Chen (WashU Biomedical Engineering) “Brain-ultrasound interface”
December 7, 2022: Matthew Ishahak (Millman lab, WashU Medicine) “Modeling Glioblastoma with Genetically Engineered Brain Organoids”
January 4, 2023: Paul Larson (University of Arizona) “Human Gene Therapy for Neurodegenerative Disorders”
February 1, 2023: Jonathan Cooper (WashU Pediatrics) “Towards therapies for the neuronal ceroid lipofuscinoses or Batten disease”
March 1, 2023: Miwei Hu, Kathleen Schoch (Miller lab, WashU Neurology) “Understanding neurofilament dynamics in ALS to guide therapeutic intervention”
April 5, 2023: Alexander Stegh (WashU Neurosurgery) “How nanotechnology changes the way we treat malignant brain tumors”
May 3, 2023: Joseph Dougherty (WashU Genetics) “Will neurodevelopmental disorders like Mytl1 haploinsufficiency be reversible?”

2021/2022 Schedule

September 22, 2021: Philip Williams (WashU Ophthalmology & Visual Sciences) “Native survival strategies of retinal ganglion cells revealed by in vivo imaging”
October 27, 2021: Fumihiko Urano (WashU Medicine) “Targeting Endoplasmic Reticulum for the Treatment of Optic Nerve Atrophy in Wolfram syndrome”
December 22, 2021: Jonathan Kipnis (WashU Pathology & Immunology) “Brain edges at the central stage of neuroimmunology”
January 26, 2022: Sidhartha Mahali (Karch lab, WashU Psychiatry) “Stem cell models of aging-related disorders”
February 23, 2022: Eric Leuthardt (WashU Neurosurgery) “Brain Computer Interfaces: Treatment of stroke and other network disorders”
March 23, 2022: Yo Sasaki (WashU Genetics) “The role of SARM1 in retinal health and disease”
April 27, 2022: Andrew Nguyen (Saint Louis University) “ASO-Based Therapeutic Approach for Progranulin-Deficient Frontotemporal Dementia (FTD)”
May 25, 2022: Andrew Yoo (WashU Developmental Biology) “Disease stage-dependent modeling of Huntington’s disease”

2020/2021 Schedule

All meetings are virtual until further notice.

September 2, 2020: Albert Kim (WashU Neurosurgery) “Schwannoma Surgery: Understanding cranial nerve tumors and cranial nerve protection”
October 7, 2020: Rie Asada (Urano lab, WashU Medicine) “Therapeutic Development for Optic nerve atrophy in Wolfram syndrome using iPSC models”
November 4, 2020: Thorold Theunissen (WashU Developmental Biology) “Understanding pluripotent stem cell states and their applications in regenerative medicine”
December 2, 2020: Lucia Capano (Yoo lab, WashU Developmental Biology) “Evaluation of miRNA-mediated direct neuronal reprogramming as a model for tauopathies”
January 6, 2021: Shuntaro Morikawa (Urano lab, WashU Medicine) “Regenerative Gene therapy for Optic Nerve Atrophy in Wolfram syndrome”
February 3, 2021: Matthew Ishahak (Millman lab, WashU Medicine) “A Microfluidic Platform for Culture and Assessment of Organoids”
March 3, 2021: Kristen Kroll (WashU Developmental Biology) “Regulatory networks that specify human cortical interneurons and their dysregulation in neurodevelopmental disorders”
April 7, 2021: William Buchser (WashU Genetics) “Neuronal Image-Based Multiplexed Assay of Variant Effects”
May 5, 2021: Kathleen Schoch (Miller lab, WashU Neurology) “Tau reduction and removal: A combination approach to therapy”

2019/2020 Schedule

There are 2 short talks (20 minutes each) at every monthly meeting.

October 2, 2019: Dan Hafez (Kim lab, WashU Neurosurgery), Shuntaro Morikawa (Urano lab, WashU Medicine)
November 6, 2019: Zhao Sun (Yoo lab, WashU Developmental Biology), Matt MacEwan (Ray lab, WashU Neurosurgery)
December 4, 2019: Fabia Filipello (Karch lab, WashU Psychiatry), Millman lab (WashU Medicine)
February 5, 2020: Rita Martinez (Karch lab, WashU Psychiatry), Kesav Meganathan (Kroll lab, WashU Developmental Biology)
March 4, 2020: Strahle lab (WashU Neurosurgery), Dezhuang Ye (Chen lab, WashU Biomedical Engineering)
CANCELLED – April 1, 2020: Theunissen lab (WashU Developmental Biology), Kathleen Schoch (Miller lab, WashU Neurology)
VIRTUAL May 6, 2020: Yi lab (WashU Dept of Neuroscience), Tom McGrath (Setton lab, WashU Biomedical Engineering)
VIRTUAL June 3, 2020: Gabel lab (WashU Dept. of Neuroscience)